What is Pharmright?
Pharmright operates at the intersection of healthtech and consumer wellness through its flagship LiviPod system. The platform provides a sophisticated, modular architecture designed to automate medication and supplement dispensing, effectively bridging the gap between clinical requirements and patient compliance. By integrating real-time alerts and a user-centric mobile application, the company addresses critical pain points for caregivers and individuals managing chronic health regimens. Unlike subscription-heavy competitors, Pharmright emphasizes a hardware-centric, accessible model that prioritizes long-term user retention and health outcomes, positioning itself as a pivotal player in the burgeoning home-health automation market.
How much funding has Pharmright raised?
Pharmright has raised a total of $3M across 3 funding rounds:
Private Equity
$902K
Series A
$1.2M
Private Equity
$865K
Private Equity (2014): $902K, investors not publicly disclosed
Series A (2015): $1.2M led by SCRA and Upstate Carolina Angel Network
Private Equity (2016): $865K, investors not publicly disclosed
Key Investors in Pharmright
SCRA
A public, non-profit corporation dedicated to fueling South Carolina's innovation economy by providing funding and support for technology-based startups and industry partnerships.
Upstate Carolina Angel Network
A member-led angel investment group focused on providing early-stage capital and mentorship to high-growth startups within the Carolina region.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Pharmright?
With the recent influx of capital, Pharmright is strategically positioned to accelerate its market penetration and refine its technological infrastructure. The company is expected to focus on expanding its distribution channels and enhancing the interoperability of the LiviPod ecosystem with existing electronic health record systems. As the demand for remote patient monitoring and automated wellness solutions continues to rise, Pharmright's focus on non-subscription, high-utility hardware provides a distinct competitive advantage. Future growth initiatives will likely involve scaling manufacturing capabilities to meet enterprise-level demand while exploring strategic partnerships with healthcare providers to integrate their dispensing technology into broader care management workflows.
See full Pharmright company page
